Karuna Therapeutics Inc
Change company Symbol lookup
Select an option...
KRTX Karuna Therapeutics Inc
SNSE Sensei Biotherapeutics Inc
ALGS Aligos Therapeutics Inc
SRRA Sierra Oncology Inc
ATOS Atossa Therapeutics Inc
OSMT Osmotica Pharmaceuticals PLC
SAND Sandstorm Gold Ltd
GRVI Grove Inc
STON Stonemor Inc
TK Teekay Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate, KarXT, is an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. It is initially developing KarXT, for the treatment of acute psychosis in patients with schizophrenia. The Company is developing a pipeline of therapeutic programs to address symptoms associated with schizophrenia and psychosis associated with Alzheimer’s disease (AD), as well as various forms of pain. KarXT is a combination of xanomeline and trospium. KarXT combines xanomeline, a muscarinic agonist, with trospium, a muscarinic antagonist, to stimulate muscarinic receptors in the CNS. It is advancing a pipeline of therapeutic programs to address the positive, negative and cognitive symptoms.

Price
Delayed
$123.83
Day's Change
-0.78 (-0.63%)
Bid
--
Ask
--
B/A Size
--
Day's High
125.49
Day's Low
121.22
Volume
(Light)

Today's volume of 14,978 shares is on pace to be much lighter than KRTX's 10-day average volume of 191,081 shares.

14,978

Climavision Honored by Goldman Sachs for Entrepreneurship

4:25 pm ET October 13, 2021 (PR Newswire) Print

Goldman Sachs (NYSE:GS) is recognizing Climavision CEO Chris Goode as one of the 100 Most Intriguing Entrepreneurs of 2021 at its Builders + Innovators Summit in Healdsburg, California.

Goldman Sachs selected Goode as one of 100 entrepreneurs from multiple industries to be honored at the two-day event. Goode co-founded Climavision earlier this year to dramatically improve weather forecasting around the United States. Climavision is developing a weather services and intelligence platform powered by a private network of high-resolution radars, GPS-RO data, and proprietary software, to vastly improve the timing and accuracy of weather forecasting, and to fill low-level gaps in existing weather surveillance.

In June, Climavision announced it had received a $100 million investment from The Rise Fund, TPG's global impact investing platform.

"I am deeply honored to receive this designation from Goldman Sachs, and it is humbling to be on a list with some of the most innovative business leaders in the world," said Goode. "It undoubtedly underscores the importance of what Climavision is doing to address climate change. We are genuinely striving the make the world a better place, and people are noticing."

"Innovation doesn't happen just anywhere; it thrives where there's a wide range of thoughts and perspectives," said David M. Solomon, Chairman & CEO of Goldman Sachs. "One of our great strengths is our ability to bring together people from different walks of life and to spark conversations today that will lead to breakthroughs tomorrow. The leaders we've chosen to highlight at our Builders + Innovators Summit are truly remarkable, and we are pleased to recognize Chris Goode as one of this year's most intriguing entrepreneurs."

In addition to honoring 100 entrepreneurs, the summit consists of general sessions and clinics led by seasoned entrepreneurs, academics and business leaders as well as resident scholars.

About Climavision Climavision brings together the power of a proprietary, high-resolution weather radar and satellite network combined with advanced weather prediction modelling and decades of industry expertise to reduce existing coverage gaps and drastically improve forecast ability. Climavision's revolutionary new approach to climate technology weather solutions is poised to help reduce the economic risks of climate change on companies, governments, and societies alike. Climavision is backed by The Rise Fund, the world's largest global impact platform committed to achieving measurable, positive social and environmental outcomes alongside competitive financial returns. The company is headquartered in Louisville, KY, with research and development operations in Raleigh, NC. To learn more, visit www.Climavision.com

Press Related Questions, please contact Patrick Scanlan at Patrick.Scanlan@gs.com.

Climavision Media Contact: Neal SteinTechnology PR Solutions321-473-7407nealjstein@techprsolutions.com

https://c212.net/c/img/favicon.png?sn=FL39191&sd=2021-10-13

View original content:https://www.prnewswire.com/news-releases/climavision-honored-by-goldman-sachs-for-entrepreneurship-301399767.html

SOURCE Climavision

https://rt.prnewswire.com/rt.gif?NewsItemId=FL39191&Transmission_Id=202110131625PR_NEWS_USPR_____FL39191&DateId=20211013

comtex tracking

COMTEX_395130275/1005/2021-10-13T16:25:53

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.